Risultati della ricerca - Isabelle Bedrosian
- Mostra 1 - 20 risultati su 59
- Vai alla pagina seguente
-
1
Contralateral prophylactic mastectomy: current perspectives di Katharine Yao, Mark Sisco, Isabelle Bedrosian
Pubblicazione 2016Revisão -
2
-
3
-
4
Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes di Amy C. Moreno, Yan Lin, Isabelle Bedrosian, Yu Shen, Gildy V. Babiera, Simona F. Shaitelman
Pubblicazione 2020Artigo -
5
Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database di Natasha M. Rueth, Heather Lin, Isabelle Bedrosian, Simona F. Shaitelman, Naoto T. Ueno, Yu Shen, Gildy V. Babiera
Pubblicazione 2014Artigo -
6
Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the N... di Samantha M. Buszek, Heather Lin, Isabelle Bedrosian, Nina Tamirisa, Gildy V. Babiera, Yu Shen, Simona F. Shaitelman
Pubblicazione 2019Artigo -
7
-
8
Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer di Anjana Bhardwaj, Harpreet Singh, Kimal Rajapakshe, Kazunoshin Tachibana, Nivetha Ganesan, Yinghong Pan, Preethi H. Gunaratne, Cristian Coarfa, Isabelle Bedrosian
Pubblicazione 2017Artigo -
9
Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor–Positive, Node-Positive Breast Cancer di Nina Tamirisa, Heather Lin, Yu Shen, Simona F. Shaitelman, Meghan Karuturi, Sharon H. Giordano, Gildy V. Babiera, Isabelle Bedrosian
Pubblicazione 2020Artigo -
10
-
11
Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surg... di Abigail S. Caudle, Isabelle Bedrosian, Denái R. Milton, Sarah M. DeSnyder, Henry M. Kuerer, Kelly K. Hunt, Elizabeth A. Mittendorf
Pubblicazione 2017Artigo -
12
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer di Julie E. Lang, Kailash Mosalpuria, Massimo Cristofanilli, Savitri Krishnamurthy, James M. Reuben, Balraj Singh, Isabelle Bedrosian, Funda Meric‐Bernstam, Anthony Lucci
Pubblicazione 2008Artigo -
13
-
14
A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients di Isabelle Bedrosian, Gildy V. Babiera, Elizabeth A. Mittendorf, Henry M. Kuerer, Laura Pantoja, Kelly K. Hunt, Savitri Krishnamurthy, Funda Meric‐Bernstam
Pubblicazione 2010Artigo -
15
Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependen... di Shuwen Xu, Gary K. Koski, Mark B. Faries, Isabelle Bedrosian, Rosemarie Mick, Markus Maeurer, Martin A. Cheever, Peter A. Cohen, Brian J. Czerniecki
Pubblicazione 2003Artigo -
16
Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population di Min Yi, Henry M. Kuerer, Elizabeth A. Mittendorf, Rosa F. Hwang, Abigail S. Caudle, Isabelle Bedrosian, Funda Meric‐Bernstam, Jamie L. Wagner, Kelly K. Hunt
Pubblicazione 2012Artigo -
17
High incidence of germline <i>BRCA</i> mutation in patients with ER low‐positive/PR low‐positive/HER‐2 <i>neu</i> negative tumors di Rachel Sanford, Juhee Song, Angelica M. Gutierrez‐Barrera, Jessica Profato, Ashley Woodson, Jennifer K. Litton, Isabelle Bedrosian, Constance T. Albarracin, Vicente Valero, Banu K. Arun
Pubblicazione 2015Artigo -
18
Trends in and Outcomes from Sentinel Lymph Node Biopsy (SLNB) Alone vs. SLNB with Axillary Lymph Node Dissection for Node-Positive Breast Cancer Patients: Experience from the SEER... di Min Yi, Sharon H. Giordano, Funda Meric‐Bernstam, Elizabeth A. Mittendorf, Henry M. Kuerer, Rosa F. Hwang, Isabelle Bedrosian, Loren L. Rourke, Kelly K. Hunt
Pubblicazione 2010Artigo -
19
Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer di Min Yi, Savitri Krishnamurthy, Henry M. Kuerer, Funda Meric‐Bernstam, Isabelle Bedrosian, Merrick I. Ross, Frederick C. Ames, Anthony Lucci, Rosa F. Hwang, Kelly K. Hunt
Pubblicazione 2008Artigo -
20
Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision di Min Yi, Funda Meric‐Bernstam, Henry M. Kuerer, Elizabeth A. Mittendorf, Isabelle Bedrosian, Anthony Lucci, Rosa F. Hwang, Jaime R. Crow, Sheng Luo, Kelly K. Hunt
Pubblicazione 2012Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Cancer
Internal medicine
Breast cancer
Oncology
Surgery
Mastectomy
Biology
Surgical oncology
Ductal carcinoma
Radiology
Sentinel lymph node
Paleontology
Pathology
Stage (stratigraphy)
Gynecology
Metastasis
Biopsy
Carcinoma
Chemotherapy
Radiation therapy
Axillary Lymph Node Dissection
Lymph node
Proportional hazards model
Axilla
Cancer research
Lobular carcinoma
Lymphovascular invasion
General surgery
Multivariate analysis